Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 Muscle Growth: Research Protocol Comparison

CJC-1295 with DAC (twice weekly) 1–2 mg subcutaneous, every 3–4 days 150–200% above baseline 1.5–2.5 kg Long-term muscle preservation, recovery enhancement, anti-aging research Best for sustained anabolic environment without daily injections. Preserves pituita

This comparison does not assign a generated winner or score.

  • CJC-1295 with DAC (twice weekly)
  • 1–2 mg subcutaneous, every 3–4 days
  • 150–200% above baseline
  • 1.5–2.5 kg
  • Long-term muscle preservation, recovery enhancement, anti-aging research
  • Best for sustained anabolic environment without daily injections. Preserves pituitary function
  • CJC-1295 No DAC (Modified GRF 1-29)
  • 100 mcg 2–3× daily
  • 100–150% above baseline (pulsatile)
  • 1.0–1.8 kg
  • Mimicking natural GH pulses, timed around training and meals
  • Requires precise timing but avoids DAC-related side effects. Ideal for short-term cycles
  • Recombinant Human GH (rhGH)
  • 2–4 IU daily subcutaneous
  • 300–500% above baseline
  • 3.0–5.0 kg
  • Rapid lean mass gain, severe GH deficiency replacement
  • Fastest results but suppresses endogenous production. Requires post-cycle recovery
  • CJC-1295 + Ipamorelin Stack
  • 1 mg CJC + 200 mcg Ipamorelin, twice weekly
  • 180–220% above baseline
  • 2.0–3.0 kg
  • Synergistic GH release from dual pathways (GHRH + ghrelin mimetic)
  • Combines pulsatile and sustained GH secretion. Popular in bodybuilding research for balanced effects
More references

Related material